{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:13:49Z","timestamp":1761862429022},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1991,6]]},"DOI":"10.1007\/bf01311239","type":"journal-article","created":{"date-parts":[[2005,3,26]],"date-time":"2005-03-26T03:14:00Z","timestamp":1111806840000},"page":"791-800","source":"Crossref","is-referenced-by-count":30,"title":["Treatment of fulminant viral hepatic failure with prostaglandin E"],"prefix":"10.1007","volume":"36","author":[{"given":"S. B.","family":"Sinclair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2008-1040593","volume":"6","author":"J Bernuau","year":"1986","unstructured":"Bernuau J, Rueff B, Benhamou J: Fulminant and subfulminant liver failure: Definitions and causes. Semin Liver Dis 6:97?106, 1986","journal-title":"Semin Liver Dis"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0300-5089(21)00017-1","volume":"10","author":"N Tygstrup","year":"1981","unstructured":"Tygstrup N, Panek L: Fulminant hepatic failure. Clin Gastroenterol 10:191?208, 1981","journal-title":"Clin Gastroenterol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2008-1040596","volume":"6","author":"N Tygstrup","year":"1986","unstructured":"Tygstrup N: Fulminant hepatic failure. Semin Liver Dis 6:137?145, 1986","journal-title":"Semin Liver Dis"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0016-5085(78)90146-4","volume":"74","author":"J Rakela","year":"1978","unstructured":"Rakela J, Redeker AG, Edwards VM, Decker BS, Overby LR, Mosley JW: Hepatitis A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology 74:879?882, 1978","journal-title":"Gastroenterology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gut.21.1.72","volume":"21","author":"LR Mathieson","year":"1980","unstructured":"Mathieson LR, Skinoj P, Nielson JO, Purcell RH, Wong D, Ranek J: Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut 21:72?77, 1980","journal-title":"Gut"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004836-198208000-00010","volume":"4","author":"BN Tandon","year":"1982","unstructured":"Tandon BN, Joshi YK, Krishnamurthy L, Tandon HD: Subacute hepatic failure: Is it a distinct entity? J Clin Gastroenterol 4:343?346, 1982","journal-title":"J Clin Gastroenterol"},{"key":"CR7","first-page":"615","volume":"44","author":"BG Gazzard","year":"1975","unstructured":"Gazzard BG: Causes of death in fulminant hepatic failure in relationship to quantitative histologic assessments of parenchymal damage. Q J Med 44:615?621, 1975","journal-title":"Q J Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archinte.1977.03630170031011","volume":"137","author":"MO Auslander","year":"1977","unstructured":"Auslander MO, Gitnick GL: Vigorous medical management of acute fulminant hepatitis. Arch Intern Med 137:599?604, 1977","journal-title":"Arch Intern Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/0016-5085(88)90011-X","volume":"94","author":"JG O'Grady","year":"1988","unstructured":"O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94:1186?1192, 1988","journal-title":"Gastroenterology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.1840070312","volume":"7","author":"RR Peleman","year":"1987","unstructured":"Peleman RR, Gavaler JS, Van Thiel DH, Esquivel C, Gordon R, Iwatsuki S, Starzl TE: Orthotopic liver transplantation for acute and subacute hepatic failure. Hepatology 7:484?489, 1987","journal-title":"Hepatology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-107-2-337","volume":"107","author":"H Bismuth","year":"1987","unstructured":"Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuau J, Rueff B, Benhamou JP: Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 107:337?341, 1987","journal-title":"Ann Intern Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0889-8553(21)00349-6","volume":"17","author":"AC Steiber","year":"1988","unstructured":"Steiber AC, Ambrosino G, Van Thiel D, Iwatsuki S, Starzl TE: Orthotopic liver transplantation for fulminant and subacute hepatic failure. Gastroenterol Clin North Am 17:157?165, 1988","journal-title":"Gastroenterol Clin North Am"},{"key":"CR13","first-page":"1104","volume":"7","author":"M Abecassis","year":"1987","unstructured":"Abecassis M, Falk R, Blendis L, Falk J, Langer B, Greig P, Superina R, Strasberg S, Taylor B, Glynn M, Levy G: Treatment of fulminant hepatic failure with a continuous infusion of prostin VR (PGE1). Hepatology 7:1104, 1987 (abstract)","journal-title":"Hepatology"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1172\/JCI113147","volume":"80","author":"M Abecassis","year":"1987","unstructured":"Abecassis M, Falk JA, Makowka L, Dindzans VJ, Falk RE, Levy GA: 16,16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte\/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest 80:881?889, 1987","journal-title":"J Clin Invest"},{"issue":"6","key":"CR15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF01072510","volume":"22","author":"HO Conn","year":"1977","unstructured":"Conn HO: Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 22(6):541?550, 1977","journal-title":"Am J Dig Dis"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(83)90336-0","volume":"85","author":"JL Dienstag","year":"1983","unstructured":"Dienstag JL: Non-A, non-B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 85:439?462, 1983","journal-title":"Gastroenterology"},{"key":"CR17","first-page":"76","volume":"207","author":"AS Milton","year":"1970","unstructured":"Milton AS, Wendlandt S: A possible role for prostaglandin E1 as a modulator for temperature regulation in the central nervous system of the cat. J Physiol 207:76, 1970","journal-title":"J Physiol"},{"key":"CR18","doi-asserted-by":"crossref","unstructured":"Lands WEM: The biosynthesis and metabolism of prostaglandins 41:633?652, 1979","DOI":"10.1146\/annurev.ph.41.030179.003221"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1073\/pnas.80.14.4349","volume":"80","author":"EA Ham","year":"1983","unstructured":"Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E, Kuehl FA: Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 80:4349?4353, 1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.125.6.2591","volume":"125","author":"JC Fantone","year":"1980","unstructured":"Fantone JC, Kunkel SL, Ward PA, Zurier RB: Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators. J Immunol 125:2591?2596, 1980","journal-title":"J Immunol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.184.4132.19","volume":"184","author":"HR Bourne","year":"1974","unstructured":"Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM: Modulation of inflammation and immunity of cyclic AMP. Science 184:19?28, 1974","journal-title":"Science"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1084\/jem.155.3.943","volume":"155","author":"RS Rappaport","year":"1982","unstructured":"Rappaport RS, Dodge GR: Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155:943?948, 1982","journal-title":"J Exp Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0090-6980(86)90011-0","volume":"32","author":"B Rush","year":"1986","unstructured":"Rush B, Merritt MV, Kaluzny M, Schoick TV, Brunden MN, Ruwart M: Studies on the mechanism of the protective action of 16,16 dimethyl PGE2 in carbon tetrachloride induced acute hepatic injury in the rat. Prostaglandins 32:439?455, 1986","journal-title":"Prostaglandins"},{"key":"CR24","first-page":"H176","volume":"238","author":"H Araki","year":"1980","unstructured":"Araki H, Lefer AM: Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol 238:H176-H180, 1980","journal-title":"Am J Physiol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/0024-3205(74)90092-7","volume":"14","author":"DC Davis","year":"1974","unstructured":"Davis DC, Potter WZ, Jollow DJ, Mitchell JR: Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci 14:2099?2103, 1974","journal-title":"Life Sci"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.1840070603","volume":"7","author":"Y Mizoguchi","year":"1987","unstructured":"Mizoguchi Y, Tsutsui H, Miyajima K, Sakagami Y, Seki S, Kobayashi K, Yamamoto S, and Morisawa S: The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology 7:1184?1188, 1987","journal-title":"Hepatology"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-8278(86)80008-3","volume":"2","author":"Y Noda","year":"1986","unstructured":"Noda Y, Hughs RD, Williams R: Effect of prostacyclin (PGI2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis. J Hepatol 2:53?64, 1986","journal-title":"J Hepatol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0016-5085(88)90562-8","volume":"94","author":"M Ogawa","year":"1988","unstructured":"Ogawa M, Mori T, Mori Y, Ueda S, Yoshida H, Kato I, Iesato K, Wakashin Y, Wakashin M, Okuda K: Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells. Gastroenterology 94:24?30, 1988","journal-title":"Gastroenterology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-8278(87)80016-8","volume":"4","author":"MH Alp","year":"1987","unstructured":"Alp MH, Hickman R: The effect of prostaglandins, branched-chain amino acids and other drugs on the outcome of experimental acute prorcine hepatic failure. J Hepatol 4:99?107, 1987","journal-title":"J Hepatol"},{"key":"CR30","first-page":"1103","volume":"19","author":"M Abecassis","year":"1987","unstructured":"Abecassis M, Falk J, Dindzans VJ, Lopatin W, Makowka L, Levy G, Falk R: Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals. Trans Proc 19:1103?1105, 1987","journal-title":"Trans Proc"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.137.12.3915","volume":"137","author":"CS Tripp","year":"1986","unstructured":"Tripp CS, Wyche A, Unanue ER, Needleman P: The functional significance of the regulation of macrophage Ia expression by endogenous arachidonate metabolitesin vitro. J Immunol 137:3915?3920, 1986","journal-title":"J Immunol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.1840080302","volume":"8","author":"A Franco","year":"1988","unstructured":"Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F: Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 8:449?454, 1988","journal-title":"Hepatology"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/299163a0","volume":"299","author":"DS Snyder","year":"1982","unstructured":"Snyder DS, Beller DI, Unanue ER: Prostaglandins modulate macrophage Ia expression. Nature 299:163?165, 1982","journal-title":"Nature"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/320543a0","volume":"320","author":"PT Massa","year":"1986","unstructured":"Massa PT, Dorries R, ter Meulen V: Viral particles induce Ia antigen expression on astrocytes. Nature 320:543?546, 1986","journal-title":"Nature"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1126\/science.3010460","volume":"232","author":"A Suzumura","year":"1986","unstructured":"Suzumura A, Lavi E, Weiss SR, Silberberg DH: Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 232:991?993, 1986","journal-title":"Science"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJM198612183152503","volume":"315","author":"JH Hoofnagle","year":"1986","unstructured":"Hoofnagle JH, Mullen KD, Jones BD, Rustgi V, DiBisceglie A, Peters M, Waggoner JG, Yoon Park BA, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: A preliminary report. N Engl J Med 315:1575?1578, 1986","journal-title":"N Engl J Med"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.1840050406","volume":"5","author":"G Dusheiko","year":"1985","unstructured":"Dusheiko G, DiBisceglie A, Bowyer S, Sachs E, Ritchie M, Schoub B, Lew M: Recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology 5:556?560, 1985","journal-title":"Hepatology"},{"issue":"5","key":"CR38","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/0016-5085(88)90018-2","volume":"94","author":"PD Berk","year":"1988","unstructured":"Berk PD, Goldberg FD: Charcoal hemoperfusion. Plus \u00e7a change, plus c'est la meme chose. Gastroenterology 94(5):1228?1230, 1988","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01311239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01311239\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01311239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T18:59:40Z","timestamp":1683053980000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01311239"}},"subtitle":["A preliminary report"],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["BF01311239"],"URL":"https:\/\/doi.org\/10.1007\/bf01311239","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}